Home » Topics » Regulatory » Patents

Patents
RSS

Astra's new antiasthmatic, antirhinitic agents

Oct. 29, 1998

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis

Oct. 29, 1998

Calpain inhibitors jointly developed by SKB and Cephalon

Oct. 29, 1998

(+)-Enantiomer of known compound acts as potent, selective NMDA receptor antagonist

Oct. 29, 1998

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Oct. 28, 1998

New serotonergic agents in development at ADIR for CNS disorders

Oct. 27, 1998

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Korean research institute develops new NMDA receptor antagonists

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...